Is this not the pertinent quote from the article:
'Bioshares analyst Mark Pachacz, who still covers the stock, says the Pfizer bid is a “fair, reasonable bid given challenges lie ahead in commercialising this technology, highlighted by recent clinical trial results showing further work needed on algorithm”.'
Is this not the pertinent quote from the article:'Bioshares...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #